ArticleFrontiers in pharmacology2012

Is there an epigenetic component underlying the resistance of triple-negative breast cancers to parp inhibitors?

Amanda Lovato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.